ArticleVaccine2008

Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A.

Claribel P Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.